Gregory J. Nadolski, M.D.

faculty photo
Associate Professor of Radiology at the Hospital of the University of Pennsylvania
Co-Director, Penn Image Guided Interventions (PIGI) Laboratory
Active Radiologist, Penn Presbyterian Medical Center
Active Radiologist, Pennsylvania Hospital
Attending Radiologist, Hospital of the University of Pennsylvania
Director Research Oversight (Interventional Radiology), University of Pennsylvania
Chair IR/DR Residency Selection Committee, University of Pennsylvania
Department: Radiology

Contact information
Hospital of the University of Pennsylvania
Department of Radiology
1 Silverstein
3400 Spruce Street
Philadelphia, PA 19104
Office: 215.662.7892
Fax: 215.615.3545
B.S. (Biochemistry)
University of Wisconsin, Madison, WI , 2001.
M.D. (Medicine)
Indiana University School of Medicine, Indianapolis, IN , 2007.
MS (Translational Research)
University of Pennsylvania, Philadelphia, PA, 2017.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

My research and clinical interests include multimodality therapies for the treatment of hepatocellular carcinoma and liver dominant metastatic cancer.
I have initiated or participated in multiple clinical trials at the Hospital of the University of Pennsylvania for treating hepatocellular carcinoma and metastatic cancers to the liver. Several of these trials are multi-modality treatments in collaboration with other medical subspecialties.

My other area of clinical and research interest is lymphatic injury, dysfunction, and malformations. Clinically, I perform thoracic duct embolization to treat chylothorax. I participate in research investigating novel lymphatic interventions to treat chylothorax, chylous ascites, refractory ascites and protein losing enteropathy.

Description of Research Expertise

My clinical and research expertise center on lymphatic interventions and multimodality cancer therapies to treat primary and secondary liver tumors. I also conduct research on diseases of the liver such as treatment of portal hypertension and ascites.

Selected Publications

Roberson JL, Rouhi AD, Bader E, Shreve L, Maguire LH, Nadolski GJ, Triggs JR, Dumon K: Outcomes in Enteral Access Based on Specialty and Approach: A Single-Center Three-Year Experience. Journal Surgical Research Aug 2023 Notes: Aug epub ahead of print.

O'Leary C, Nadolski G, Kovach SJ 3rd, Zheng J, Cohen A, Kaplan DE, Itkin M: Thoracic Duct-Venous Junction Obstruction as Unknown Cause of Abdominal Pain: Diagnosis and Treatment. Radiology Aug 2023 Notes: Aug epub ahead of print.

Hung ML, Nadolski GJ, Mondschein J, Cobb R, Trerotola SO: Outcomes following Exchange and Upsizing of Malfunctioning Small-Caliber Double-J Ureteral Stents. JVIR Jul 2023 Notes: July epub ahead of print.

McGraw JR, Kiefer RM, Shah A, Clark TWI, Shlansky-Goldberg RD, Nadolski GJ, Hunt SJ, Gade TP.: Outcomes of Transarterial Embolization for Acute Nonvariceal Upper Gastrointestinal Bleeding: Correlation with Periprocedural Endoscopy. JVIR 34(6): 1062-1069, June 2023.

Matsumoto MM, Shamimi-Noori S, Gade TP, Hoffmann JC, Nadolski GJ, DePietro DM.: A 5-Year Update on the IR Residency Match: 2022 National Survey Results of Program Directors and Matched Applicants Compared with 2017. JVIR May 2023 Notes: Online ahead of print DOI: 10.1016/j.jvir.2023.05.013.

Seyferth ER, Itkin M, Nadolski GJ: Intranodal Glue Embolization for Postoperative Lymphatic Leaks in the Groin and Pelvis: Comparison with Sclerotherapy. JVIR 34(4): 600-606, April 2023.

Currie BM, Bakhtiar M, Nadolski GJ, Soulen MC: Mitigation of Sarcopenia after Peritoneovenous Shunt Placement in Patients with Refractory Ascites. JVIR 34(4): 633-638, Apr 2023 Notes: DOI: 10.1016/j.jvir.2022.12.037.

M. Matsumoto, D. DePietro, S. Shamimi-Noori, J. Hoffmann, T. Gade, S. Reddy G. Nadolski: Integrated IR Residency: Perspectives of Applicants and Program Directors from the 2022 Match. JVIR 34(3): S51-2, March 2023.

M. Matsumoto, D. DePietro, S. Shamimi-Noori, J. Hoffmann, T. Gade S. Reddy, G. Nadolski: Changes in the Match: Results of an IR Applicant and Program Director Survey Regarding Virtual Interviews and Step 1 Pass/Fail. JVIR 34(3): S49, March 2023.

J. Crainic, K. Weinfurtner, I. Gatmaytan, G. Nadolski, S. Hunt, T. Gade: Genetically Determined Metabotype Renders β-Catenin Mutant Hepatocellular Carcinomas Susceptible to Treatment Induced Ischemia. JVIR 34(3): S147, March 2023.

back to top
Last updated: 08/23/2023
The Trustees of the University of Pennsylvania